Cargando…
Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome()
BACKGROUND: High-sensitivity cardiac troponin T (hsTnT) was recently approved for clinical use by the Food and Drug Administration. The transition from contemporary to hsTnT assays requires a thorough understanding of the clinical differences between these assays. HYPOTHESIS: HsTnT may provide a mor...
Autores principales: | Magnoni, Marco, Gallone, Guglielmo, Ceriotti, Ferruccio, Vergani, Vittoria, Giorgio, Daniela, Angeloni, Giulia, Maseri, Attilio, Cianflone, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011041/ https://www.ncbi.nlm.nih.gov/pubmed/29942855 http://dx.doi.org/10.1016/j.ijcha.2018.06.004 |
Ejemplares similares
-
“Summer Shift”: A Potential Effect of Sunshine on the Time Onset of ST‐Elevation Acute Myocardial Infarction
por: Cannistraci, Carlo Vittorio, et al.
Publicado: (2018) -
Use of conventional cardiac troponin assay for diagnosis of non-ST-elevation myocardial infarction: ‘The Ottawa Troponin Pathway’
por: Thiruganasambandamoorthy, Venkatesh, et al.
Publicado: (2020) -
Completing the job: The advantage of complete revascularization in ST-elevation myocardial infarction over culprit-only revascularization strategies
por: Moroni, Francesco, et al.
Publicado: (2020) -
The assessment of high sensitivity cardiac troponin in patients with COVID-19: A multicenter study
por: Perrone, Marco Alfonso, et al.
Publicado: (2021) -
Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay
por: Damen, Sander A. J., et al.
Publicado: (2019)